Plain-English translation of NCT05901259 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The EXOPULSE Study is tracking how a wearable suit called the EXOPULSE Mollii Suit or EXOPULSE Suit affects muscle tension, strength, blood circulation, and chronic pain in people with neurological conditions. The suit delivers gentle electrical stimulation to help relax muscles and reduce discomfort. You would be measured before, during, and after using the suit to see what changes happen over time.
Many people with conditions like cerebral palsy, stroke, multiple sclerosis, and fibromyalgia struggle with tight muscles and chronic pain that limit their daily lives. This study is gathering real-world evidence about whether this treatment can help ease these symptoms and improve quality of life.
You likely qualify if…
You likely don't qualify if…
You would use the EXOPULSE suit as part of your regular treatment routine. Researchers will measure how your muscles respond, your pain levels, and blood circulation before you start, while you're using the suit, and after you finish. These measurements use standard tests that are already part of normal care, so there are no extra procedures — just careful tracking of how you're doing over time.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Sweden
Sponsor
Exoneural Network AB
Enrollment target
~200 participants
Started
February 2026
Primary completion
August 2027
Age range
2 Years and older
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Milana Mileusnic, PhD
Otto Bock Healthcare Products GmbH
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.